Abbott's Closer
This article was originally published in The Gray Sheet
Executive Summary
Next-generation vascular closure device gains FDA market go-ahead for use in minimally invasive closure of femoral artery access sites following diagnostic procedures such as coronary angioplasty. Made by Abbott's newly acquired Perclose unit, the Closer takes "less than half the time" of current Perclose closure devices